Back to results
US 2006/0216302 A1Published application
Immunological markers
OwnerRobert Root-Bernsteininventor
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
OwnerRobert Root-Bernsteininventor
Estimating the term…
Compounds, compositions and methods for identifying human or other animals having a particular characteristic, by administration of an antigenic marker that elicits a unique antigenic response. Compositions comprise: (a) an antigenic marker; and (b) a pharmaceutically-acceptable carrier wherein said marker does not elicit a vaccination immune response. In a preferred embodiment, the composition additionally comprises a vaccination antigen effective against organisms such as Mycobacterium, human immunodeficiency virus (HIV), 10 hepatitis C, Espstein-Barr virus, cytomegalovirus virus, E. coli feline leukemia virus, foot-and-mouth virus, and canine distemper virus. The present invention also provides methods for tracking a subject having a given characteristic in a population of animal subjects. The tracking is performed by administering an antigenic marker to the individual to produce antibodies that are unique to the antigenic marker and then screening the population to identify the individual based on the presence of the marker antibodies.
-177. (canceled)
A biomarker composition for administration to a human or other animal subject, comprising:
A method of raising unique antibodies in an animal subject, comprising administering to said subject a composition comprising an antigenic marker, wherein said marker does not elicit a vaccination immune response in said subject.
A method of immunizing an individual at risk of being infected by a pathogen, comprising administering to said individual a vaccine comprising:
A method for marking an individual subject having a given characteristic in a population of animal subjects, comprising:
A method for identifying subjects having a given characteristic in a population of animal subjects, comprising:
An identification kit, for identifying an animal subject having been administered an antigenic marker, comprising:
An antigenic marker peptide, comprising from about 12 to about 30 amino acid residues at least about 50% of which are selected from the group consisting of His, Trp, Arg, Met, Gln, Tyr, Cys, Phe, Asn, Asp, Lys, and mixtures thereof, wherein said marker is substantially immunogenic, antigenically unique, and does not create a significant adverse immune response in a human or other animal subject.
A method of selecting a marker, comprising:
A tracking system for tracking individual animal subjects having a characteristic in a population of subjects, comprising:
An administration system for tracking animal subjects in a population of subjects having characteristics comprising a first characteristic and a second characteristic, wherein:
A method for tracking individual animal subjects having a characteristic in a population of subjects having a plurality of characteristics, comprising:
A database for use in a system for tracking animal subjects having a plurality of characteristics, comprising:
A biomarker composition, for administration to a human or other animal subject, comprising:
A method for marking an individual subject having a given characteristic in a population of animal subjects, comprising:
Dependencies are inferred from the claim text.